SEC Tracker
Get the app

Sanara MedTech SMTI

Sanara MedTech faces merger delay

Merger communication

Form
425
Filed
Importance
Routine
  1. Merger with MiMedx pending FTC review
  2. Second Request from FTC extends HSR Act waiting period
  3. Merger remains subject to regulatory approval

Written from the 425 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Sanara MedTech files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3842 and related industry codes: the same peer list as the financial tables.

  1. Anika Therapeutics ANIK public float $147M, Jun 30, 2025
  2. Stereotaxis STXS public float $150M, Jun 30, 2025
  3. Profound Medical PROF public float $152M, Jun 30, 2025
  4. Sight Sciences SGHT public float $154M, Jun 30, 2025
  5. AVITA Medical RCEL public float $139M, Jun 30, 2025